Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
levodropropizine + chlorpheniramine maleate
- Development stage
- Unknown
- Lead developer
- Crest Lifesciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Levodropropizine + chlorpheniramine maleate is a fixed-dose combination pharmaceutical product developed by Crest Lifesciences for the treatment of dry, irritating coughs and allergy-related respiratory symptoms. It consists of levodropropizine, a non-opioid antitussive that suppresses the cough reflex through central action in the medulla oblongata and peripheral effects, and chlorpheniramine maleate, a first-generation H1 receptor antagonist that competes with histamine to alleviate allergic reactions in the respiratory tract. The drug is formulated as a syrup and is approved for marketing in India, typically indicated for coughs associated with respiratory tract infections and allergies.
- Other names
- levodropropizine and chlorpheniramine maleate
02
Targets
mAChR (Muscarinic acetylcholine receptors)HRH1 (Histamine H1 Receptor)ADRA1A (α1A)
Beyond the preview
Go deeper on levodropropizine + chlorpheniramine maleate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on levodropropizine + chlorpheniramine maleate.